These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12533083)

  • 1. Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease.
    Wolozin B
    Arch Neurol; 2003 Jan; 60(1):16-8. PubMed ID: 12533083
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.
    Papassotiropoulos A; Streffer JR; Tsolaki M; Schmid S; Thal D; Nicosia F; Iakovidou V; Maddalena A; Lütjohann D; Ghebremedhin E; Hegi T; Pasch T; Träxler M; Brühl A; Benussi L; Binetti G; Braak H; Nitsch RM; Hock C
    Arch Neurol; 2003 Jan; 60(1):29-35. PubMed ID: 12533085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
    Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
    Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.
    Tedde A; Rotondi M; Cellini E; Bagnoli S; Muratore L; Nacmias B; Sorbi S
    Neurobiol Aging; 2006 May; 27(5):773.e1-773.e3. PubMed ID: 16055229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
    Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
    Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.
    Wang B; Zhang C; Zheng W; Lu Z; Zheng C; Yang Z; Wang L; Jin F
    Neurosci Lett; 2004 Oct; 369(2):104-7. PubMed ID: 15450677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyp46 polymorphisms in Alzheimer's disease: a review.
    Garcia AN; Muniz MT; Souza e Silva HR; da Silva HA; Athayde-Junior L
    J Mol Neurosci; 2009 Nov; 39(3):342-5. PubMed ID: 19705089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of CYP46 and risk for Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Berciano J
    Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP46: a risk factor for Alzheimer's disease or a coincidence?
    Golanska E; Hulas-Bigoszewska K; Wojcik I; Rieske P; Styczynska M; Peplonska B; Pfeffer A; Luczywek E; Wasiak B; Gabryelewicz T; Religa D; Chodakowska-Zebrowska M; Barcikowska M; Sobow T; Liberski PP
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):105-8. PubMed ID: 15936520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.
    Desai P; DeKosky ST; Kamboh MI
    Neurosci Lett; 2002 Aug; 328(1):9-12. PubMed ID: 12123847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
    Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
    Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
    Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
    Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.
    Kabbara A; Payet N; Cottel D; Frigard B; Amouyel P; Lambert JC
    Neurosci Lett; 2004 Jun; 363(2):139-43. PubMed ID: 15172102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
    Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
    Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
    Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.
    Helisalmi S; Vepsäläinen S; Koivisto AM; Mannermaa A; Iivonen S; Hiltunen M; Kiviniemi V; Soininen H
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):421-2. PubMed ID: 16484661
    [No Abstract]   [Full Text] [Related]  

  • 17. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Wu CB; Tang MN; Hong Z
    J Mol Neurosci; 2012 Jul; 47(3):514-8. PubMed ID: 22528464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
    Golanska E; Hulas-Bigoszewska K; Sieruta M; Zawlik I; Witusik M; Gresner SM; Sobow T; Styczynska M; Peplonska B; Barcikowska M; Liberski PP; Corder EH
    J Alzheimers Dis; 2009; 17(2):359-68. PubMed ID: 19363267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
    Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.
    Juhász A; Rimanóczy A; Boda K; Vincze G; Szlávik G; Zana M; Bjelik A; Pákáski M; Bódi N; Palotás A; Janka Z; Kálmán J
    Neurochem Res; 2005 Aug; 30(8):943-8. PubMed ID: 16258842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.